In one study, even supra-pharmacologic bolus doses of GLP-1 provided only transient glucose reductions and often triggered nausea/vomiting (due to high peak levels) ( [42] ) ( [77] )
While this pack was designed to ease common digestive side effects of GLP-1 therapy, its also ideal for anyone experiencing bloating, irregularity, or gut discomfort
The new Phase 3 efficacy numbers According to Lillys May 21, 2026 release, the primary endpoint at 80 weeks showed the following mean body-weight changes: 4 mg: -19.0% ( -47.2 lbs ) 9 mg: -25.9% ( -64.4 lbs ) 12 mg: -28.3% ( -70.3 lbs ) placebo: -2.2% ( -5.5 lbs ) 1 That is already enough to make the trial one of the most important obesity readouts of the year
Just turn the temperature to between 36F and 46F (2C to 8C)
In particular, these are drugs known by the acronym GLP-1 , widely used in recent years for their effectiveness in promoting weight loss